Home › Macular Degeneration › Florida › Tampa
Macular Degeneration clinical trials in Tampa, FL
5 studies for Macular Degeneration are looking for participants at sites in and around Tampa (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
RecruitingPhase 2/3
- Retina Associates of Florida, LLC, Tampa
- Retina Vitreous Associates of Florida, Tampa
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
RecruitingPhase 3
- University of South Florida Ophthalmology, Tampa
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
RecruitingPhase 2
- Retina Associates of Florida, LLC, Tampa
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
RecruitingPhase 1/2
- Retina Vitreous Associates of Florida, Tampa
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
RecruitingPhase 3
- Retina Vitreous Associates of Florida, Tampa
About Macular Degeneration
Macular degeneration, or age-related macular degeneration (AMD), causes vision loss in older adults. Learn about the types and what can help.
More about Macular Degeneration on MedlinePlus
Macular Degeneration trials in other cities
- Dallas, TX13 studies
- Erie, PA10 studies
- The Woodlands, TX9 studies
- Sacramento, CA8 studies
- Reno, NV8 studies
- Hagerstown, MD8 studies
- Phoenix, AZ7 studies
- Cleveland, OH7 studies
- Houston, TX7 studies
- Salt Lake City, UT7 studies
- Boston, MA7 studies
- Austin, TX7 studies
Other studies in Tampa
- Non-Small Cell Lung Cancer51 studies
- Breast Cancer43 studies
- Cancer (all types)39 studies
- Colorectal Cancer33 studies
- Metastatic Cancer29 studies
- Lung Cancer29 studies
- Acute Myeloid Leukemia29 studies
- Pancreatic Cancer26 studies
- Ovarian Cancer21 studies
- Myelodysplastic Syndromes19 studies
- Melanoma19 studies
- Heart Failure18 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.